Jasper Therapeutics, Inc. - *W EXP 09/24/202 (JSPRW) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2021 to Q3 2025

Type / Class
Equity / *W EXP 09/24/202
Symbol
JSPRW on Nasdaq
Price per share
$0.11
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
3,372,631
Total reported value
$1,091,685
% of total 13F portfolios
0%
Share change
+289,589
Value change
+$844,317
Number of holders
9
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 30 Sep 2025, 9 institutional investors reported holding 3,372,631 shares of Jasper Therapeutics, Inc. - *W EXP 09/24/202 (JSPRW).

Institutional Holders of Jasper Therapeutics, Inc. - *W EXP 09/24/202 (JSPRW) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 3,372,631 $1,091,685 +$844,317 $0.08 9
2025 Q2 3,148,378 $389,343 +$270,938 $0.12 8
2025 Q1 913,904 $129,017 -$1,793 $0.14 6
2024 Q4 926,806 $193,117 -$441,092 $0.21 5
2024 Q3 3,131,813 $625,708 +$7,100 $0.20 5
2024 Q2 3,096,314 $618,935 +$27,189 $0.20 5
2024 Q1 2,958,733 $538,489 +$15,712 $0.18 4
2023 Q4 2,956,318 $236,269 +$57,062 $0.08 6
2023 Q3 2,399,469 $120,701 -$13,822 $0.05 8
2023 Q2 2,451,254 $344,547 +$40,100 $0.14 10
2023 Q1 2,159,744 $430,950 +$136,308 $0.20 10
2022 Q4 1,794,499 $54,474 -$5,907 $0.03 11
2022 Q3 1,976,740 $133,000 +$3,680 $0.07 12
2022 Q2 1,960,448 $179,000 -$2,251 $0.09 12
2022 Q1 1,582,599 $429,000 -$143,677 $0.27 13
2021 Q4 2,014,163 $2,970,000 -$731,361 $1.47 15
2021 Q3 2,491,723 $3,670,000 +$3,670,000 $1.48 16